Literature DB >> 16507858

Can heart rate variation rule out sleep-disordered breathing in heart failure?

A Vazir1, M Dayer, P C Hastings, H F McIntyre, M Y Henein, P A Poole-Wilson, M R Cowie, M J Morrell, A K Simonds.   

Abstract

In patients with obstructive sleep apnoea (OSA), the very low frequency power spectral density index (VLFI) derived from analysis of heart rate correlates with the severity of obstructive apnoeas. VLFI is also associated with Cheyne-Stokes respiration/central sleep apnoea (CSR/CSA) in congestive heart failure (CHF). The present authors have tested the hypothesis that per cent VLFI, derived from a standard Holter ECG recording, can be used to detect the presence of OSA and CSR/CSA in patients with mild-to-moderate CHF. In total, 60 CHF patients underwent polysomnography with monitoring of heart rate. Data from 33 patients were analysed for per cent VLFI. Of the 60 patients, 27 were excluded due to atrial fibrillation, extensive pacing or frequent ventricular extra systoles. Receiver operator characteristic curves were constructed to establish the per cent VLFI that would optimally identify the presence or absence of sleep-disordered breathing. Using an apnoea-hypopnoea index>20 events.h-1 and setting the per cent VLFI at 2.23% yielded a sensitivity of 85%, specificity of 65%, positive predictive value of 61% and a negative predictive value of 87%. The latter increased to 100% when using an apnoea-hypopnoea cut-off of 30 events.h-1. In conclusion, these results suggest that spectral analysis of heart rate may be useful as a "rule-out test" for sleep-disordered breathing in patients with mild-to-moderate congestive heart failure.

Entities:  

Mesh:

Year:  2006        PMID: 16507858     DOI: 10.1183/09031936.06.00130904

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

Review 1.  Phosphinic peptides as zinc metalloproteinase inhibitors.

Authors:  V Dive; D Georgiadis; M Matziari; A Makaritis; F Beau; P Cuniasse; A Yiotakis
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  Assessment of respiratory flow cycle morphology in patients with chronic heart failure.

Authors:  Ainara Garde; Leif Sörnmo; Pablo Laguna; Raimon Jané; Salvador Benito; Antoni Bayés-Genís; Beatriz F Giraldo
Journal:  Med Biol Eng Comput       Date:  2016-04-23       Impact factor: 2.602

3.  Use of high-frequency peak in spectral analysis of heart rate increment to improve screening of obstructive sleep apnoea.

Authors:  Laurent Poupard; Isabelle Court-Fortune; Vincent Pichot; Florian Chouchou; Jean-Claude Barthélémy; Frédéric Roche
Journal:  Sleep Breath       Date:  2010-11-21       Impact factor: 2.816

4.  Multi-modal ECG Holter system for sleep-disordered breathing screening: a validation study.

Authors:  Laurent Poupard; Marc Mathieu; Michael Goldman; Florian Chouchou; Frédéric Roche
Journal:  Sleep Breath       Date:  2011-07-26       Impact factor: 2.816

5.  Inhibition of hydrogen sulfide restores normal breathing stability and improves autonomic control during experimental heart failure.

Authors:  Rodrigo Del Rio; Noah J Marcus; Harold D Schultz
Journal:  J Appl Physiol (1985)       Date:  2013-02-28

Review 6.  [Sleep-related breathing disorders and (resulting) cardiovascular diseases].

Authors:  O Oldenburg; T Bitter; H Fox; D Horstkotte
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.